Jay R. Luly
2012
In 2012, Jay R. Luly earned a total compensation of $771.6K as President and Chief Executive Officer at Enanta Pharmaceuticals, a 26% increase compared to previous year.
Compensation breakdown
| Bonus | $213,914 |
|---|---|
| Option Awards | $145,736 |
| Salary | $407,482 |
| Other | $4,439 |
| Total | $771,571 |
Luly received $407.5K in salary, accounting for 53% of the total pay in 2012.
Luly also received $213.9K in bonus, $145.7K in option awards and $4.4K in other compensation.
Rankings
In 2012, Jay R. Luly's compensation ranked 7,189th out of 11,487 executives tracked by ExecPay. In other words, Luly earned more than 37.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,189 out of 11,487 | 37th |
Division Manufacturing | 2,572 out of 4,253 | 40th |
Major group Chemicals And Allied Products | 658 out of 1,198 | 45th |
Industry group Drugs | 455 out of 920 | 51st |
Industry Pharmaceutical Preparations | 358 out of 700 | 49th |
Source: SEC filing on January 15, 2015.
Luly's colleagues
We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2012.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019